Mitralign Percutaneous Annuloplasty System
Commercial- Indications
- Mitral valve regurgitation
Company intelligence / Profile preview
Mitralign
Tewksbury, Massachusetts, United Statesforbion.com ↗
- Ownership
- Private
- Development stage
- Commercial
01
Overview
The company developed the Mitralign System, a catheter-based percutaneous annuloplasty device for treating functional mitral and tricuspid regurgitation. Early clinical results showed successful reduction of mitral regurgitation severity and positive patient outcomes post-procedure. The company completed enrollment in an EU study for CE Mark approval and performed first-in-human cases with both its mitral and tricuspid systems[1][2][3][4].
In March 2019, Edwards Lifesciences acquired certain assets of Mitralign, including intellectual property related to its annuloplasty systems[6].
No commercial launch as an independent entity; assets now belong to Edwards Lifesciences.
Pipeline breadth before acquisition was limited—primarily focused on two programs/devices.
No recent updates as an independent company post-acquisition.
- Therapeutic areas
- Cardiovascular
- Modalities
- DeviceNon-pharmacological therapy
- Industry
- Therapeutic Medical Devices
02
Drug pipeline
2 assets1 more asset in the full pipeline.
Request access →03
Partnerships
MedtronicJohnson & Johnson Development Corporation
Beyond the preview
Go deeper on Mitralign.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Mitralign.